Delia Ciobotaru reviews a recent randomised controlled trial on the neurocognitive effects of transcranial direct current stimulation in depression.
[read the full story...]
Delia Ciobotaru reviews a recent randomised controlled trial on the neurocognitive effects of transcranial direct current stimulation in depression.
[read the full story...]
Andres Fonseca summarises a recent RCT which finds that apps for depression and anxiety in an IAPT service can be effective and cost effective.
[read the full story...]
John Baker reviews a pilot randomised controlled trial of cognitive-behavioural suicide prevention therapy for mental health inpatients, which found that the therapy was acceptable and feasible to deliver.
[read the full story...]
Georgie Parker reviews a US cluster randomised controlled trial which finds that digital CBT is effective at reducing eating disorder symptoms in female college students.
[read the full story...]
Pascal Immanuel Michael reviews a randomised controlled trial examining long-term outcomes of psilocybin-assisted psychotherapy for existential distress in patients with cancer.
[read the full story...]
Zoe Stoneley reviews a Taiwanese study on nicotine replacement therapy and healthy lifestyle psychoeducation for smoking reduction in acute psychiatric inpatients.
[read the full story...]
Hilary Shepherd summarises a recent randomised controlled trial comparing music therapy to music listening for children with autism spectrum disorder.
[read the full story...]
Anya Borissova summarises the therapeutic mechanisms of psilocybin in treatment-resistant depression and changes noticed in the amygdala and prefrontal cortex during emotional processing.
[read the full story...]
Vishal Bhavsar reviews a recent study examining correlates of future violent behaviour in people being treated for schizophrenia in US-based treatment centres.
[read the full story...]
In her debut blog, Rosa Pitts summarises the ARIES trial, which suggests it may be feasible to use a smartphone app (My Journey 3) to help prevent relapse in psychosis, although questions remain about long-term participant engagement with the app.
[read the full story...]